

Scientists from the University of Edinburgh have shown that the protein Mbd3 plays a crucial role in the process by which embryonic stem cells become specialised cells, such as brain or skin cells. These findings make significant advances in understanding how embryonic stem cells can be made to become all the different types of cell in the body, ultimately to be used in replacement therapies for specific diseases and injuries. This research is published online this week in the leading scientific journal Nature Cell Biology.
In the body, stem cells divide to produce both copies of themselves and other, more specialised, cell types. The Edinburgh scientists made mouse embryonic stem cells lacking the Mbd3 protein. Unlike non-engineered cells, the Mbd3-lacking cells failed to form different cell types when induced to do so in a dish, but rather remained in an uncommitted state. When injected into very early mouse embryos, the Mbd3-lacking cells behaved in a similar way, disrupting the normal development of the embryo.
Brian Hendrich, leading the research team, says “It is well established that embryonic stem cells need certain factors to sustainably make copies of themselves, that is, to self-renew. We have now shown, for the first time, that to leave that state and go down the specialisation pathway cells require the activity of Mbd3; it is not enough simply to remove the self-renewal factors. If Mbd3 is absent, the cells remain in an embryonic stem cell-like state”.
These latest findings will also provide insights into some of the crucial differences between mouse and human embryonic stem cells. Mouse embryonic stem cells need the protein LIF to be able to make copies of themselves indefinitely; human embryonic stem cells, on the other hand, do not need LIF to keep multiplying. Mbd3-lacking cells are similar to human embryonic stem cells in that they do not require LIF. They may, therefore, be used as a tool to understand how human embryonic cells bypass the need for LIF when multiplying without limit.
Mbd3 is part of a large complex of proteins called the NuRD (Nucleosome Remodelling and Histone Deacetylation) complex. NuRD is known as an epigenetic silencer, as its role in cells is to turn genes off.
This research was supported by The Wellcome Trust, the MRC and the BBSRC.
Ana Coutinho | Source: alphagalileo
Further information: www.iscr.ed.ac.uk
More articles from
Life Sciences:
Scientists find new insight into genome of neglected malaria parasite
10.10.2008 | Emory University
Hodgkin lymphoma -- new characteristics discovered
10.10.2008 | Helmholtz Association of German Research Centres
Scientists find new insight into genome of neglected malaria parasite
10.10.2008 | Life Sciences
Hodgkin lymphoma -- new characteristics discovered
10.10.2008 | Life Sciences
Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
10.10.2008 | Life Sciences